Given the correlation between activation of cGAS/STING signaling and type I interferon innate immune responses, we next sought to assess the effects of Olaparib in combination with CDC7 inhibition on anti‐tumor immunity in vitro. This evidence concerns the gene CDC7 and neoplasm.